Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
作者信息
Moore C K, O'Connell J B, Renlund D G, Bristow M R, Hammond E H
机构信息
Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, Salt Lake City.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):1055-8.
PMID:1899151
Abstract
摘要
相似文献
1
Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.在未致敏情况下使用OKT3预防时的心脏同种异体移植细胞排斥反应。
Transplant Proc. 1991 Feb;23(1 Pt 2):1055-8.
2
Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.
J Heart Lung Transplant. 1991 Mar-Apr;10(2):217-21; discussion 221-2.
3
Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
Transplant Proc. 1987 Apr;19(2 Suppl 1):45-53.
4
Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.心脏移植受者使用OKT3单克隆抗体进行诱导免疫抑制。
Transplant Proc. 1990 Oct;22(5):2319.
5
Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection.心脏移植中抗OKT3的抗鼠抗体：对排斥反应预防和再治疗的意义。
Transplant Proc. 1991 Feb;23(1 Pt 2):1157-9.
6
Some aspects of changed histopathologic appearance of acute rejection in cardiac allografts after prophylactic application of OKT3.预防性应用OKT3后心脏同种异体移植急性排斥反应组织病理学改变的某些方面。
J Heart Lung Transplant. 1991 May-Jun;10(3):366-72.
7
8
Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
J Heart Transplant. 1990 Jan-Feb;9(1):1-9, discussion 9-10.
9
Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.采用多疗程OKT3治疗难治性、复发性心脏排斥反应。
J Heart Transplant. 1990 Nov-Dec;9(6):724-6.
10
Nashville antithymocyte serum: a safe and efficacious agent for prophylaxis after heart transplantation.纳什维尔抗胸腺细胞血清：心脏移植术后预防用的一种安全有效的药物。
Transplant Proc. 1991 Feb;23(1 Pt 2):1160-1.
引用本文的文献
1
Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.莫罗单抗-CD3：对其药理学及作为实体器官移植排斥反应预防药物应用的重新评估。
Drugs. 1996 May;51(5):865-94. doi: 10.2165/00003495-199651050-00010.
Zotero 插件